GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » PB Ratio

NextCell Pharma AB (OSTO:NXTCL) PB Ratio : 0.91 (As of May. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-24), NextCell Pharma AB's share price is kr1.485. NextCell Pharma AB's Book Value per Share for the quarter that ended in Feb. 2024 was kr1.62. Hence, NextCell Pharma AB's PB Ratio of today is 0.91.

Good Sign:

NextCell Pharma AB stock PB Ratio (=0.79) is close to 10-year low of 0.77

The historical rank and industry rank for NextCell Pharma AB's PB Ratio or its related term are showing as below:

OSTO:NXTCL' s PB Ratio Range Over the Past 10 Years
Min: 0.77   Med: 3.46   Max: 28.43
Current: 0.92

During the past 9 years, NextCell Pharma AB's highest PB Ratio was 28.43. The lowest was 0.77. And the median was 3.46.

OSTO:NXTCL's PB Ratio is ranked better than
84.77% of 1313 companies
in the Biotechnology industry
Industry Median: 2.54 vs OSTO:NXTCL: 0.92

During the past 12 months, NextCell Pharma AB's average Book Value Per Share Growth Rate was -41.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 29.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 43.10% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of NextCell Pharma AB was 106.60% per year. The lowest was -18.80% per year. And the median was 25.55% per year.

Back to Basics: PB Ratio


NextCell Pharma AB PB Ratio Historical Data

The historical data trend for NextCell Pharma AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB PB Ratio Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
PB Ratio
Get a 7-Day Free Trial Premium Member Only 4.59 9.41 3.32 1.89 1.63

NextCell Pharma AB Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 1.95 1.63 1.63 1.64

Competitive Comparison of NextCell Pharma AB's PB Ratio

For the Biotechnology subindustry, NextCell Pharma AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's PB Ratio falls into.



NextCell Pharma AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

NextCell Pharma AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Feb. 2024)
=1.485/1.624
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


NextCell Pharma AB  (OSTO:NXTCL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


NextCell Pharma AB PB Ratio Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB (OSTO:NXTCL) Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines